EchoGo® Heart Failure vs Imbio PHA (4.0.0)
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These two tools are adjacent rather than direct competitors, as they leverage different imaging modalities for distinct cardiac assessments. EchoGo® Heart Failure analyzes echocardiograms to detect HFpEF, while Imbio PHA processes CT pulmonary angiograms to measure cardiac structures for pulmonary embolism and hypertension risk stratification. Therefore, the choice between them depends entirely on the specific imaging data available and the target cardiac condition being investigated.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGou00ae Heart Failure (Tool A) analyzes routine echocardiograms to detect HFpEF. Imbio PHA (Tool B) processes CT pulmonary angiogram (CTPA) scans to measure cardiac structures for assessing right ventricular dilation and aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension.
EchoGou00ae Heart Failure (Tool A) is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. For Imbio PHA (Tool B), pricing information requires contacting the company, and specific reimbursement details are not provided.
EchoGou00ae Heart Failure (Tool A) is clinically validated with 90% sensitivity and 86% specificity for HFpEF detection and was trained on over 10 years of outcome data. Imbio PHA (Tool B) utilizes AI algorithms for anatomical identification and measurement to provide automated measurements, but specific sensitivity or specificity metrics are not detailed in the provided information.
EchoGou00ae Heart Failure (Tool A) delivers insights within 20 minutes. Imbio PHA (Tool B) provides rapid, fully-automated assessment, typically in minutes.
EchoGou00ae Heart Failure (Tool A) targets Cardiology, Emergency Medicine, and Internal Medicine. Imbio PHA (Tool B) is relevant for Cardiology, Pulmonology, and Radiology specialties.
EchoGou00ae Heart Failure (Tool A) generates automated structured reports and integrates seamlessly with existing workflows and IT stacks, with DICOM workflow for report delivery to PACS. Imbio PHA (Tool B) generates annotated DICOM images and summary reports in PDF format, integrating with native DICOM tools and workflows.